https://preview.redd.it/82r3nb28e7ch1.png?width=2104&format=png&auto=webp&s=afc027c1d81b57c01acde1c98aaf10e7ec967b57
**Good morning, SqueezeFinders!**
**Yesterday's price action on the $QQQ tech index was largely insignificant as it was just rangebound chop after a close at 711.44 (+0.28%). We won't have clarity on directional sentiment until we're either below 700 or above 730. The situation in the Middle-East seems to be escalating as the MoU/ceasefire agreement has fallen into jeopardy after bombings have resumed, and the Strait of Hormuz looks to be imminently closed again. For this reason, I have kept focus on anything with relative strength, some small cap oil, and biotechs as they have retained strength despite the turmoil. The main directional sentiment determinants today are a mix of the below-detailed economic data releases, and further developments regarding the situation in the Middle-East. Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar to track irregularities in our data, or check out our automated trading robot, SqueezeBot to get an edge on the market without having to stare at the screen all day long.**
**🥇 Gold: \~$4,080/oz (-0.1%)**
**🥈 Silver: \~$59/oz (-0.2%)**
**🪙 Bitcoin: \~$62.0k/coin (-1.8%)**
**🛢️ Oil: \~$74.20/barrel (+1.0%)**
**Today's economic data releases are:**
**🇺🇸 Initial Jobless Claims @ 8:30AM ET**
**🇺🇸 Continuing Jobless Claims @ 8:30AM ET**
**🇺🇸 FOMC Member Williams Speaks @ 9:00AM ET**
**🇺🇸 Existing Home Sales (Jun) @ 10:00AM ET**
**🇺🇸 30-Year Bond Auction @ 1:00PM ET**
**📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.**
**📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.**
**4. $ARQT**
**Squeezability Score: 45%**
**Juice Target: 40.9**
**Confidence: 🍊 🍊**
**Price: 28.50 (+3.0%)**
**Breakdown point: 25.5**
**Breakout point: 31.8**
**Mentions (30D): 0 🆕**
**Event/Condition: FDA approval of ZORYVE cream label expansion for pediatric psoriasis patients as young as age 2 significantly broadening addressable market + raised full-year 2026 revenue guidance to $480-495 million on robust Q1 sales growth of 65% YoY + launch of new virtual health platform improving patient access and supporting ZORYVE adoption + Recent price target 🎯 of $36 from Needham + Recent price target 🎯 of $34 from Morgan Stanley + Recent price target 🎯 of $35 from Mizuho Securities**
**5. $WULF**
**Squeezability Score: 39%**
**Juice Target: 66.3**
**Confidence: 🍊 🍊**
**Price: 22.83 (+12.8%)**
**Breakdown point: 20.0**
**Breakout point: 25.8**
**Mentions (30D): 1**
**Event/Condition: Announced transformative 20-year $19 billion lease agreement with Anthropic for Justified Data AI campus providing massive long-term revenue visibility + sale of majority stake in Abernathy joint venture to Fluidstack generating substantial cash proceeds at premium valuation + strong analyst upgrades following AI pivot and infrastructure expansion momentum + Recent price target 🎯 of $72 from Morgan Stanley + Recent price target 🎯 of $33 from Needham + Recent price target 🎯 of $36 from Cantor Fitzgerald**
**Gain access to all our cutting-edge research tools, live watchlists, alerts, and more:** [**https://www.squeeze-finder.com/subscribe**](https://www.squeeze-finder.com/subscribe)
**HINT: Use code RDDT to get your first month for just $10!**
**NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY**